Search Interest in Lymphatic Drainage Enzyme Supplements Grows in 2026 as Consumers Explore Fluid Balance, Nattokinase Research, and Weight Management Connections Aurora, CO, April 14, 2026 (GLOBE ...
A 2026 informational overview of Ankalax ankle massager brace marketing claims, heat therapy and vibration compression technology, recovery positioning, and what consumers should verify before ...
Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a stock option to purchase 2,500,000 shares of Geron ...
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a ...
HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT) ...
The patient was dosed at Austin Health in Melbourne, Australia, under the supervision of Professor Hui Gan. IPAX BrIGHT is assessing the safety and efficacy of TLX101-Tx in combination with ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Aligos remains blinded to participant-level data. Completion of enrollment in the HBeAg- cohort is expected in the second half of 2026. Currently, there are 74 participants enrolled in the HBeAg- ...
These advancements are driven by R37, the Company’s advanced AI lab dedicated to revolutionizing healthcare financial performance through scaled and practical innovation. R1 recently opened a new R37 ...
“Ensight 2.2 gives customers an unprecedented way to see and use their imaging data,” said Michael Sistenich, CEO of Enlitic. “Instead of treating imaging data as a black box, this release helps teams ...
The series is presented by VICHY Laboratoires, with support from Organon Canada and Hologic Canada, media partner Healthing.ca, and founding partner Shoppers Foundation for Women’s Health™.
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it will highlight recent commercial achievements leading to the ...